Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study.
Alberto FlorisElisabetta ChessaGian Domenico SebastianiImmacolata PreveteFlorenzo IannoneLaura ColadonatoMarcello GovoniAlessandra BortoluzziMarta MoscaChiara TaniAndrea DoriaLuca IaccarinoFranco FranceschiniMicaela FrediFabrizio ContiFrancesca Romana SpinelliFrancesca BellisaiRoberto D'AlessandroAnna ZanettiGreta CarraraCarlo Alberto ScirèAlberto CauliMatteo Piganull nullPublished in: RMD open (2023)
Tapering PDN <5 mg/day was achieved and maintained in half of newly diagnosed patients with SLE and may represent a good balance between the need to prevent damage accrual and the risk of disease relapse.